Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05372484 · ClinicalTrials.gov registry record · NA
Rice Technologies for Cervical Cancer Screening and Diagnosis
A NA study of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
- Recruiting
- Registry status
- NA
- Development phase
- 678
- Enrollment target
- 4
- Study locations
NCT05372484: Recruiting NA study of Cervical Cancer, sponsored by M.D. Anderson Cancer Center.
NCT05372484 is a NA study of Cervical Cancer that is actively recruiting participants, run by M.D. Anderson Cancer Center. The registered enrollment target is 678 participants, above the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target (20% higher). The trial reports 4 study locations across 2 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05372484, a NA study of Cervical Cancer, is actively recruiting participants, sponsored by M.D. Anderson Cancer Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 678 participants
- Enrollment target
- 4
- Study locations
Study Summary
The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopathology.
Primary Outcome
Image data will be used as a training set to develop and refine image analysis algorithms. Multimodal Mobile Colposcope will be compared with colposcopic impression considering clinical performance (sensitivity, specificity, positive and negative predictive values, and area under the Receiver Operating Characteristic (ROC) curve)
Conditions Studied
Interventions
- DEVICE Multimodal optical imaging
Study Locations (4)
Other
- José Macamo General Hospital and Health Center - Maputo
- Maputo Central Hospital - Maputo
- Mavalane Hospital and Health Center - Maputo
Texas
- M D Anderson Cancer Center - Houston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 678 participants |
| Start Date | 2021-03-24 |
| Est. Completion | 2028-03-30 |
| Phase | NA |
What NCT05372484 shows while recruiting
NCT05372484 is an interventional study that assigns participants to a tested intervention. The registered 678 participants enrollment target is mid-sized for trials with a published cap, above the 566-participant average among 144 other Cervical Cancer trials with a reported enrollment target (20% higher).
The record links to 1 condition, with Cervical Cancer appearing as the primary indexed condition, and to 1 intervention - of which Multimodal optical imaging is the first listed.
NCT05372484 reports a single indexed study location in Other, Texas.
Frequently Asked Questions
What is clinical trial NCT05372484 about?
NCT05372484 is a clinical study titled "Rice Technologies for Cervical Cancer Screening and Diagnosis". The study aims to compare the accuracy of the lateral flow test to detect HPV at the POC with commercially available HPV test and to determine the diagnostic accuracy and reliability of a multimodal optical imaging system to detect cervical dysplasia, with the gold reference standard of histopatholo...
What is the current status of trial NCT05372484?
This trial is currently recruiting. It is a NA study. The enrollment target is 678 participants. The study started on 2021-03-24. Estimated completion is 2028-03-30.
What conditions does trial NCT05372484 study?
This clinical trial studies the following conditions: Cervical Cancer.
What interventions are being tested in trial NCT05372484?
The interventions under investigation include: Multimodal optical imaging (DEVICE).
Who is sponsoring clinical trial NCT05372484?
This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05372484 being conducted?
This trial has 4 study locations across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cervical Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05372484's enrollment target sits among peer trials
678 23rd of 144 higher than 122 of 144 other Cervical Cancer trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Cervical Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
PopSci CHW4CervixHealth
RECRUITING · NA
-
ASk Questions in GYnecologic Oncology (ASQ-GYO)
RECRUITING · NA
-
ACCESS: Accelerating Cervical Cancer Elimination Through the Integration of Screen-and-treat Services
RECRUITING · NA
-
Improving Care for Rural Patients With Solid Tumors
RECRUITING · NA
-
Self-Collection of the Pap Smear as Agency: A Novel Way to Improve Refractory Low Cervical Cancer Screening Rates in Rural Alabama
RECRUITING · NA
-
Physical Activity Intervention Among Older Women With Gynecologic Cancers (Fit4Treatment)
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06436924 · 678 participants
Safety and Efficacy of Workflows of High Volume Single Operators in a LAAO Device Implant Procedural Day
- NCT03501706 · 680 participants · NA
An Assessment of Cognitive Improvement Training Among Mid-life Individuals
- NCT05626452 · 680 participants · NA
PrEP Optimization Among Women to Enhance Retention and Uptake
- NCT05753748 · 680 participants · NA
Surveillance vs. Endoscopic Therapy for Barrett's Esophagus With Low-grade Dysplasia
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI